Results 291 to 300 of about 164,269 (359)

Fetuin B aggravates liver X receptor-mediated hepatic steatosis through AMPK in HepG2 cells and mice.

open access: green, 2019
Wenjing Zhou   +6 more
openalex   +1 more source

Obstructive sleep apnea and cardiovascular disease in individuals with metabolic dysfunction‐associated fatty liver disease: A prospective cohort study

open access: yesSleep Research, EarlyView.
Abstract Objective To assess the association between obstructive sleep apnea (OSA) risk levels and major cardiovascular disease (CVD) subtypes in individuals with metabolic dysfunction‐associated fatty liver disease (MAFLD). Methods This cohort study included 128,022 MAFLD participants from the UK Biobank without CVD at baseline.
Haizhen Chen   +4 more
wiley   +1 more source

FGF1 ameliorates hepatic steatosis through acute activation of the unfolded protein response and VLDL production. [PDF]

open access: yesJHEP Rep
van Zutphen T   +10 more
europepmc   +1 more source

Serum LEAP-2 as a Potential Biomarker for Hepatic Steatosis in Adolescents with Obesity and MASLD: A Cross-Sectional Study. [PDF]

open access: yesDiagnostics (Basel)
Çakar S   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy